S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Twitter executive responsible for content safety resigns after Elon Musk criticism
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Twitter executive responsible for content safety resigns after Elon Musk criticism
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Twitter executive responsible for content safety resigns after Elon Musk criticism
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Twitter executive responsible for content safety resigns after Elon Musk criticism
Laser breakthrough could send stock soaring 2,467% (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
LON:PRM

Proteome Sciences (PRM) Share Forecast, Price & News

GBX 4.97
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
4.64
5.40
50-Day Range
3.36
5.35
52-Week Range
3.15
5.45
Volume
170,202 shs
Average Volume
299,113 shs
Market Capitalization
£14.69 million
P/E Ratio
418.00
Dividend Yield
N/A
Price Target
N/A

PRM stock logo

About Proteome Sciences (LON:PRM) Stock

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Receive PRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter.

PRM Stock News Headlines

“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Proteome Sciences
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Proteome Sciences : Price Monitoring Extension
Proteome Sciences : AGM Statement
Proteome Sciences : Result of AGM
Proteome Sciences PLC
Proteome Sciences PLCShs Stock , PMSNF
See More Headlines

PRM Price History

PRM Company Calendar

Last Earnings
8/10/2020
Today
6/03/2023

Industry, Sector and Symbol

Industry
Medical Laboratories & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Net Income
£1.32 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.78 million
Cash Flow
GBX 1.33 per share

Miscellaneous

Free Float
N/A
Market Cap
£14.69 million
Optionable
Not Optionable
Beta
0.01

Key Executives

  • Dr. Mariola Sohngen (Age 61)
    CEO & Exec. Director
    Comp: $258k
  • Dr. Ian H. Pike
    Chief Scientific Officer & Exec. Director
  • Mr. Richard Paul Dennis (Age 63)
    Chief Commercial Officer & Exec. Director
    Comp: $225k
  • Mr. Abdelghani Omari (Age 45)
    CFO & Director
  • Mr. Glenn Barney
    VP of Sales & Marketing
  • Victoria Birse
    Company Sec.













PRM Stock - Frequently Asked Questions

How have PRM shares performed in 2023?

Proteome Sciences' stock was trading at GBX 3.50 on January 1st, 2023. Since then, PRM stock has increased by 42.1% and is now trading at GBX 4.98.
View the best growth stocks for 2023 here
.

How were Proteome Sciences' earnings last quarter?

Proteome Sciences plc (LON:PRM) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Proteome Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK).

What is Proteome Sciences' stock symbol?

Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM."

How do I buy shares of Proteome Sciences?

Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Proteome Sciences' stock price today?

One share of PRM stock can currently be purchased for approximately GBX 4.98.

How much money does Proteome Sciences make?

Proteome Sciences (LON:PRM) has a market capitalization of £14.69 million and generates £7.78 million in revenue each year.

How can I contact Proteome Sciences?

Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The official website for the company is www.proteomics.com. The company can be reached via phone at +44-20-70432116.

This page (LON:PRM) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -